Area of research
Cardiology and Cardiovascular Medicine · Genetics
Research interest
Research interests include Neurogenetic and Muscular Disorders Research, Atrial Fibrillation Management and Outcomes, Cardiac Arrhythmias and Treatments, and Cardiac pacing and defibrillation studies.
Multicenter Study on the Safety of Pulsed Field Ablation in Over 40,000 Patients
Video-Based Biomechanical Analysis Captures Disease-Specific Movement Signatures of Different Neuromuscular Diseases
Defect imaging via adjoint-state-based Reverse-time Migration
215PVideo-based biomechanical analysis captures disease-specific movement signatures of myotonic dystrophy and facioscapulohumeral muscular dystrophy
224PDelayed exercise recovery ventilatory responses between individuals with neuromuscular disease
24ODEVOTE part C results: exploring higher doses of nusinersen in nusinersen-experienced participants with spinal muscular atrophy (SMA)
593PLongitudinal assessment of 4-year HFMSE changes in SMA II and III patients treated with nusinersen
511PA real-world perspective on longitudinal quantitative muscle strength in treated adults with SMA
372PIntegrating cognition and neuroimaging: a study of cerebral regions in myotonic dystrophy
223PPrediction of VO2max and cardiopulmonary responses from ventilatory threshold VO2 in neuromuscular disease patients using machine learning
301PPatterns of volume and fat infiltration in skeletal muscle of adults with spinal muscular atrophy
594PEvaluating oxygen saturation and recovery dynamics in skeletal muscle during exercise in adults with spinal muscular atrophy
Determining minimal clinically important differences in the Hammersmith Functional Motor Scale Expanded for untreated spinal muscular atrophy patients: An international study
Upper limb function changes over 12 months in untreated SMA II and III individuals: an item-level analysis using the Revised Upper Limb Module
Two-year efficacy and safety of risdiplam in patients with type 2 or non-ambulant type 3 spinal muscular atrophy (SMA)
Genetic analysis and natural history of Charcot-Marie-Tooth disease CMTX1 due to <i>GJB1</i> variants
Correction to: Two‑year efficacy and safety of risdiplam in patients with type 2 or non‑ambulant type 3 spinal muscular atrophy (SMA)
SUNFISH Parts 1 and 2: 4-year Efficacy and Safety Data of Risdiplam in Types 2 and 3 Spinal Muscular Atrophy (SMA) (S34.009)
FIREFISH Parts 1 and 2: 36-month safety and efficacy of risdiplam in Type 1 spinal muscular atrophy (SMA) (P7-9.009)
P230 Safety update: Risdiplam clinical trial program for spinal muscular atrophy (SMA)
Atrial Cardiomyopathy: From Cell to Bedside
MECP2-related pathways are dysregulated in a cortical organoid model of myotonic dystrophy
P.128 Integrated analyses of data from clinical trials of delandistrogene moxeparvovec in DMD
Major Adverse Dystrophinopathy Event Score as Marker of Cumulative Morbidity and Risk for Mortality in Boys with Duchenne Muscular Dystrophy
Nusinersen in pediatric and adult patients with type III spinal muscular atrophy
Reldesemtiv in Patients with Spinal Muscular Atrophy: a Phase 2 Hypothesis-Generating Study
Long-term outcomes in patients treated with flecainide for atrial fibrillation with stable coronary artery disease
Revised upper limb module in type II and III spinal muscular atrophy: 24-month changes
Advances in the Therapy of Spinal Muscular Atrophy
Subtropical and Tropical American Estuaries: A Session of the International Estuarine Research Conference; October, 1987; New Orleans, Louisiana
U.S.-Netherlands Cooperative Research: A Study of the Role of Hydrology on Wetland Structure and Productivity (Ecosystem Studies)
Nutrient and Light Dynamics in Relation to Seagrass (Thalassia Testudinum) Community Production in Laguna De Terminos, Campeche, Mexico
An Ecological Study of the Laguna De Terminos (Campeche, Mexico) With Special Reference to Fishery Resources and the Potential Impact of Man